Clinical Trial Update: A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy [Phase 4]

View source ↗

Summary

A Phase 4 randomized clinical trial is testing intravenous methylprednisolone using two protocols in Graves' ophthalmopathy. The study status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Methylprednisolone (intravenous) (methylprednisolone)

Snippet

Sponsor: Third Affiliated Hospital, Sun Yat-Sen University | Conditions: Graves Ophthalmopathy | Phase 4 | Status: NOT_YET_RECRUITING